Figure 1
Cumulative risk of premature menopause by cumulative dose of procarbazine among women treated for Hodgkin lymphoma with procarbazine-containing chemotherapy regimens.

Cumulative risk of premature menopause by cumulative dose of procarbazine among women treated for Hodgkin lymphoma with procarbazine-containing chemotherapy regimens.

Close Modal

or Create an Account

Close Modal
Close Modal